John E. Kalachnik

452 total citations
18 papers, 313 citations indexed

About

John E. Kalachnik is a scholar working on Psychiatry and Mental health, Neurology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, John E. Kalachnik has authored 18 papers receiving a total of 313 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Psychiatry and Mental health, 3 papers in Neurology and 3 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in John E. Kalachnik's work include Schizophrenia research and treatment (9 papers), Attention Deficit Hyperactivity Disorder (6 papers) and Epilepsy research and treatment (6 papers). John E. Kalachnik is often cited by papers focused on Schizophrenia research and treatment (9 papers), Attention Deficit Hyperactivity Disorder (6 papers) and Epilepsy research and treatment (6 papers). John E. Kalachnik collaborates with scholars based in United States. John E. Kalachnik's co-authors include Robert L. Sprague, Kenneth D. Gadow, Rina K. Ullmann and Esther K. Sleator and has published in prestigious journals such as Journal of Autism and Developmental Disorders, The Journal of Nervous and Mental Disease and Developmental Medicine & Child Neurology.

In The Last Decade

John E. Kalachnik

17 papers receiving 278 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John E. Kalachnik United States 11 220 90 59 57 46 18 313
Ekkehart Staufenberg United Kingdom 7 116 0.5× 116 1.3× 91 1.5× 65 1.1× 35 0.8× 14 294
Alia Shakiba Iran 10 156 0.7× 110 1.2× 101 1.7× 31 0.5× 16 0.3× 23 345
James P. Mayo United States 12 118 0.5× 72 0.8× 64 1.1× 42 0.7× 17 0.4× 20 308
Glenn Richmond United States 8 194 0.9× 107 1.2× 66 1.1× 19 0.3× 14 0.3× 17 361
Sunnie Kenowsky United States 7 121 0.6× 66 0.7× 26 0.4× 6 0.1× 12 0.3× 10 259
Deirdre Carroll United States 8 141 0.6× 156 1.7× 130 2.2× 23 0.4× 5 0.1× 10 261
Erin Shepherd Canada 6 244 1.1× 242 2.7× 204 3.5× 85 1.5× 28 0.6× 7 503
Jarrett Barnhill United States 7 84 0.4× 76 0.8× 81 1.4× 13 0.2× 4 0.1× 18 199
Leonardo Cortese Canada 11 343 1.6× 59 0.7× 125 2.1× 9 0.2× 61 1.3× 13 424
Valentina Baglioni Italy 11 82 0.4× 106 1.2× 149 2.5× 19 0.3× 34 0.7× 26 280

Countries citing papers authored by John E. Kalachnik

Since Specialization
Citations

This map shows the geographic impact of John E. Kalachnik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John E. Kalachnik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John E. Kalachnik more than expected).

Fields of papers citing papers by John E. Kalachnik

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John E. Kalachnik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John E. Kalachnik. The network helps show where John E. Kalachnik may publish in the future.

Co-authorship network of co-authors of John E. Kalachnik

This figure shows the co-authorship network connecting the top 25 collaborators of John E. Kalachnik. A scholar is included among the top collaborators of John E. Kalachnik based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John E. Kalachnik. John E. Kalachnik is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Kalachnik, John E.. (2012). Applied monitoring for tardive dyskinesia and other extrapyramidal side effects. Mental Health Clinician. 1(7). 159–163. 1 indexed citations
2.
Kalachnik, John E., et al.. (2003). Brief Report: Clonazepam Behavioral Side Effects with an Individual with Mental Retardation. Journal of Autism and Developmental Disorders. 33(3). 349–354. 8 indexed citations
3.
Kalachnik, John E., et al.. (2002). Benzodiazepine Behavioral Side Effects: Review and Implications for Individuals With Mental Retardation. American Journal on Mental Retardation. 107(5). 376–376. 42 indexed citations
4.
Kalachnik, John E., et al.. (2000). Results of barbiturate antiepileptic drug discontinuation on antipsychotic medication dose in individuals with intellectual disability. Journal of Intellectual Disability Research. 44(2). 155–163. 12 indexed citations
5.
Kalachnik, John E.. (1999). Measuring side effects of psychopharmacologic medication in individuals with mental retardation and developmental disabilities. Mental Retardation and Developmental Disabilities Research Reviews. 5(4). 348–359. 19 indexed citations
6.
Kalachnik, John E., et al.. (1995). Antiepileptic drug behavioral side effects in individuals with mental retardation and the use of behavioral measurement techniques.. PubMed. 33(6). 374–82. 18 indexed citations
7.
Kalachnik, John E. & Robert L. Sprague. (1994). How Well Do Physicians, Pharmacists, and Psychologists Assess Tardive Dyskinesia Movements?. Annals of Pharmacotherapy. 28(2). 185–190. 7 indexed citations
8.
Kalachnik, John E. & Robert L. Sprague. (1993). The Dyskinesia Identification System Condensed User Scale (DISCUS): reliability, validity, and a total score cut‐off for mentally ill and mentally retarded populations. Journal of Clinical Psychology. 49(2). 177–189. 35 indexed citations
9.
Kalachnik, John E., et al.. (1992). Phenobarbital Exacerbation of Self-Injurious Behavior. The Journal of Nervous and Mental Disease. 180(11). 732–732. 9 indexed citations
10.
Kalachnik, John E., et al.. (1992). A case of phenobarbital exacerbation of a preexisting maladaptive behavior partially suppressed by chlorpromazine and misinterpreted as chlorpromazine efficacy. Research in Developmental Disabilities. 13(4). 381–392. 12 indexed citations
11.
Sprague, Robert L. & John E. Kalachnik. (1991). Reliability, validity, and a total score cutoff for the dyskinesia identification system: condensed user scale (DISCUS) with mentally ill and mentally retarded populations.. PubMed. 27(1). 51–8. 43 indexed citations
12.
Kalachnik, John E., et al.. (1988). Training clinical personnel to assess for tardive dyskinesia. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 12(5). 749–762. 13 indexed citations
13.
Kalachnik, John E., et al.. (1987). Psychotropic drug use with successful and unsuccessful community placed developmentally disabled groups. Research in Developmental Disabilities. 8(2). 191–202. 8 indexed citations
14.
Kalachnik, John E., et al.. (1986). Tardive dyskinesia: Update for the mental health administrator. PubMed. 13(2). 1–8. 3 indexed citations
15.
Kalachnik, John E., et al.. (1985). Tardive Dyskinesia: Facts the mental health administrator may not know. PubMed. 12(2). 22–27. 4 indexed citations
16.
Sprague, Robert L., et al.. (1984). The dyskinesia identification system--Coldwater (DIS-Co): a tardive dyskinesia rating scale for the developmentally disabled.. PubMed. 20(2). 328–38. 17 indexed citations
17.
Kalachnik, John E., et al.. (1982). Effect of Methylphenidate Hydrochloride on Stature of Hyperactive Children. Developmental Medicine & Child Neurology. 24(6). 586–595. 29 indexed citations
18.
Gadow, Kenneth D. & John E. Kalachnik. (1981). Prevalence and pattern of drug treatment for behavior and seizure disorders of TMR students.. PubMed. 85(6). 588–95. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ekkehart Staufenberg Breakdown of academic impact, for papers by Alia Shakiba Breakdown of academic impact, for papers by James P. Mayo Breakdown of academic impact, for papers by Glenn Richmond Breakdown of academic impact, for papers by Sunnie Kenowsky Breakdown of academic impact, for papers by Deirdre Carroll Breakdown of academic impact, for papers by Erin Shepherd Breakdown of academic impact, for papers by Jarrett Barnhill Breakdown of academic impact, for papers by Leonardo Cortese Breakdown of academic impact, for papers by Valentina Baglioni
Rankless by CCL
2026